Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFOX8 vs mFOLFOX6 Combined With Targeted Therapy in First-Line Metastatic Colorectal Cancer
NCT07621497Phase 2Not yet recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Nov 2026
- Primary completion
- Nov 2029
- Countries
- 1
01
Overview
A Phase 2 trial of levoleucovorin in colorectal cancer (CRC), sponsored by Sun Yat-sen University. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
levoleucovorin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07621497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07621497.